These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10403362)

  • 1. Postmenopausal hormone therapy increases risk of deep vein thrombosis and pulmonary embolism.
    Ambrus JL
    Am J Med; 1999 Jul; 107(1):104. PubMed ID: 10403362
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of hormonal therapy related thrombosis.
    Sandset PM
    Thromb Res; 2013 Jan; 131 Suppl 1():S4-7. PubMed ID: 23452740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).
    Høibraaten E; Qvigstad E; Arnesen H; Larsen S; Wickstrøm E; Sandset PM
    Thromb Haemost; 2000 Dec; 84(6):961-7. PubMed ID: 11154141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and venous thromboembolism.
    Walker ID
    Thromb Res; 2005 Feb; 115 Suppl 1():88-92. PubMed ID: 15790166
    [No Abstract]   [Full Text] [Related]  

  • 5. Massive mesenteric and portal venous thrombosis secondary to hormone replacement therapy.
    Watt DG; Shapter O; Mittapalli D; Murray WG
    Scott Med J; 2013 Nov; 58(4):e8-10. PubMed ID: 24215058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy, thrombosis and thrombophilia.
    Keeling DM
    J Br Menopause Soc; 2005 Jun; 11(2):74-5. PubMed ID: 15970020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone replacement and venous thromboembolism following hip and knee arthroplasty.
    Hurbanek JG; Jaffer AK; Morra N; Karafa M; Brotman DJ
    Thromb Haemost; 2004 Aug; 92(2):337-43. PubMed ID: 15269830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and risk of venous thromboembolism--still unresolved questions.
    Sandset PM
    J Thromb Haemost; 2006 Jan; 4(1):68-9. PubMed ID: 16409452
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial.
    Schierbeck LL; Rejnmark L; Tofteng CL; Stilgren L; Eiken P; Mosekilde L; Køber L; Jensen JE
    BMJ; 2012 Oct; 345():e6409. PubMed ID: 23048011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progestogens and venous thromboembolism among postmenopausal women using hormone therapy.
    Canonico M; Plu-Bureau G; Scarabin PY
    Maturitas; 2011 Dec; 70(4):354-60. PubMed ID: 22024394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk assessment for recurrent venous thrombosis.
    Olié V; Plu-Bureau G; Canonico M; Scarabin PY
    Lancet; 2011 Mar; 377(9771):1072; author reply 1073-4. PubMed ID: 21440798
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex hormones and thrombosis.
    Watson HG
    Semin Hematol; 2007 Apr; 44(2):98-105. PubMed ID: 17433902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.
    Douketis JD; Julian JA; Crowther MA; Kearon C; Bates SM; Barone M; Piovella F; Middeldorp S; Prandoni P; Johnston M; Costantini L; Ginsberg JS
    Clin Appl Thromb Hemost; 2011; 17(6):E106-13. PubMed ID: 21159708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and arterial thrombotic disease.
    Middeldorp S
    Thromb Res; 2005 Feb; 115 Suppl 1():68-71. PubMed ID: 15790160
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].
    Canonico M; Scarabin PY
    Med Sci (Paris); 2008 Mar; 24(3):228-31. PubMed ID: 18334161
    [No Abstract]   [Full Text] [Related]  

  • 16. Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.
    Olié V; Canonico M; Scarabin PY
    Curr Opin Hematol; 2010 Sep; 17(5):457-63. PubMed ID: 20601871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term hormonal treatment for transgender people.
    den Heijer M; Bakker A; Gooren L
    BMJ; 2017 Nov; 359():j5027. PubMed ID: 29192092
    [No Abstract]   [Full Text] [Related]  

  • 18. Postmenopausal hormone replacement therapy: how could we have been so wrong?
    Laine C
    Ann Intern Med; 2002 Aug; 137(4):290. PubMed ID: 12186521
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy and cardiovascular disease: increased risks of venous thromboembolism and stroke, and no protection from coronary heart disease.
    Lowe GD
    J Intern Med; 2004 Nov; 256(5):361-74. PubMed ID: 15485471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
    Lekovic D; Miljic P; Dmitrovic A; Thachil J
    Blood Rev; 2017 May; 31(3):151-157. PubMed ID: 27998619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.